Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha.
Moschella F, Buccione C, Ruspantini I, Castiello L, Rozo Gonzalez A, Iacobone F, Ferraresi V, Palermo B, Nisticò P, Belardelli F, Proietti E, Macchia I, Urbani F. Moschella F, et al. Front Oncol. 2023 May 18;13:1145667. doi: 10.3389/fonc.2023.1145667. eCollection 2023. Front Oncol. 2023. PMID: 37274275 Free PMC article.
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Urbani F, Ferraresi V, Capone I, Macchia I, Palermo B, Nuzzo C, Torsello A, Pezzotti P, Giannarelli D, Pozzi AF, Santaquilani M, Roazzi P, Bastucci S, Catricalà C, La Malfa A, Vercillo G, Gualtieri N, Buccione C, Castiello L, Cognetti F, Nisticò P, Belardelli F, Moschella F, Proietti E. Urbani F, et al. Among authors: moschella f. Front Oncol. 2020 Mar 6;10:202. doi: 10.3389/fonc.2020.00202. eCollection 2020. Front Oncol. 2020. PMID: 32211314 Free PMC article.
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Rozera C, Cappellini GA, D'Agostino G, Santodonato L, Castiello L, Urbani F, Macchia I, Aricò E, Casorelli I, Sestili P, Montefiore E, Monque D, Carlei D, Napolitano M, Rizza P, Moschella F, Buccione C, Belli R, Proietti E, Pavan A, Marchetti P, Belardelli F, Capone I. Rozera C, et al. Among authors: moschella f. J Transl Med. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5. J Transl Med. 2015. PMID: 25933939 Free PMC article. Clinical Trial.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Nisticò P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Aricò E, Valentini M, Bracci L, Cognetti F, Ciccarese M, Vercillo G, Roselli M, Fossile E, Tosti ME, Wang E, Marincola F, Imberti L, Catricalà C, Natali PG, Belardelli F, Proietti E. Nisticò P, et al. Among authors: moschella f. Int J Cancer. 2009 Jan 1;124(1):130-9. doi: 10.1002/ijc.23886. Int J Cancer. 2009. PMID: 18839429 Free article. Clinical Trial.
Exploiting dendritic cells in the development of cancer vaccines.
Bracci L, Capone I, Moschella F, Proietti E, Belardelli F. Bracci L, et al. Among authors: moschella f. Expert Rev Vaccines. 2013 Oct;12(10):1195-210. doi: 10.1586/14760584.2013.836905. Epub 2013 Oct 4. Expert Rev Vaccines. 2013. PMID: 24090117 Free article. Review.
171 results